These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
443 related items for PubMed ID: 27861987
1. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer. Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kikuchi Y, Otsuka Y, Kaneko H, Igarashi Y, Sumino Y. J Clin Ultrasound; 2017 Mar 04; 45(3):138-144. PubMed ID: 27861987 [Abstract] [Full Text] [Related]
2. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma. Iwamoto T, Imai Y, Kogita S, Igura T, Sawai Y, Fukuda K, Yamaguchi Y, Matsumoto Y, Nakahara M, Morimoto O, Seki Y, Ohashi H, Fujita N, Kudo M, Takehara T. Dig Dis; 2016 Mar 04; 34(6):679-686. PubMed ID: 27750237 [Abstract] [Full Text] [Related]
3. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. J Magn Reson Imaging; 2011 Aug 04; 34(2):326-35. PubMed ID: 21780227 [Abstract] [Full Text] [Related]
4. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI. Yang WY, Park HS, Kim YJ, Yu MH, Jung SI, Jeon HJ. J Clin Ultrasound; 2017 Nov 12; 45(9):542-550. PubMed ID: 28547764 [Abstract] [Full Text] [Related]
9. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases. Asato N, Tsurusaki M, Sofue K, Hieda Y, Katsube T, Kitajima K, Murakami T. Jpn J Radiol; 2017 Apr 12; 35(4):197-205. PubMed ID: 28251499 [Abstract] [Full Text] [Related]
10. Comparison of Sonazoid-Contrast‑Enhanced Ultrasound and Gd‑EOB‑DTPA‑Enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma. Huang Z, Zhu RH, Li SS, Luo HC, Li KY. Ultrasound Med Biol; 2024 Sep 12; 50(9):1339-1345. PubMed ID: 38824054 [Abstract] [Full Text] [Related]
11. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases? Tajima T, Akahane M, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, Kokudo N, Ohtomo K. Jpn J Radiol; 2012 Oct 12; 30(8):648-58. PubMed ID: 22836904 [Abstract] [Full Text] [Related]
12. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS. Eur J Radiol; 2013 May 12; 82(5):822-8. PubMed ID: 23287713 [Abstract] [Full Text] [Related]
13. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma. Kang HJ, Lee JM, Yoon JH, Han JK. Korean J Radiol; 2021 Mar 12; 22(3):354-365. PubMed ID: 33236540 [Abstract] [Full Text] [Related]
14. Combining the Arterial Phase of Contrast-Enhanced Ultrasonography, Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging in the Diagnosis of Hepatic Nodules ≤20 mm in Patients with Cirrhosis. Zhou Y, Jing X, Zhang X, Ding J, Wang Y, Zhou H, Zhang Q, Chen Y, Yue W. Ultrasound Med Biol; 2019 Mar 12; 45(3):693-701. PubMed ID: 30606633 [Abstract] [Full Text] [Related]
15. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM. Br J Radiol; 2012 Jul 12; 85(1015):980-9. PubMed ID: 22167501 [Abstract] [Full Text] [Related]
16. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J. Invest Radiol; 2010 Mar 12; 45(3):133-41. PubMed ID: 20098330 [Abstract] [Full Text] [Related]
18. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE. Invest Radiol; 2011 Sep 12; 46(9):548-55. PubMed ID: 21577131 [Abstract] [Full Text] [Related]
19. Histology-Based Assessment of Sonazoid-Enhanced Ultrasonography for the Diagnosis of Liver Metastasis. Kobayashi K, Maruyama H, Kiyono S, Yokosuka O, Ohtsuka M, Miyazaki M, Matsushima J, Kishimoto T, Nakatani Y. Ultrasound Med Biol; 2017 Oct 12; 43(10):2151-2158. PubMed ID: 28755791 [Abstract] [Full Text] [Related]